Addy Alt‐Holland

597 total citations
17 papers, 476 citations indexed

About

Addy Alt‐Holland is a scholar working on Cell Biology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Addy Alt‐Holland has authored 17 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cell Biology, 9 papers in Molecular Biology and 5 papers in Immunology and Allergy. Recurrent topics in Addy Alt‐Holland's work include Cellular Mechanics and Interactions (8 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cell Adhesion Molecules Research (5 papers). Addy Alt‐Holland is often cited by papers focused on Cellular Mechanics and Interactions (8 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Cell Adhesion Molecules Research (5 papers). Addy Alt‐Holland collaborates with scholars based in United States, Germany and Tunisia. Addy Alt‐Holland's co-authors include Jonathan A. Garlick, Yulia Shamis, Norbert E. Fusenig, Mark W. Carlson, Christophe Egles, Weitian Zhang, Alexander R. Margulis, Howard C. Crawford, Teresa M. DesRochers and Larry A. Feig and has published in prestigious journals such as Cancer Research, Oncogene and Journal of Cell Science.

In The Last Decade

Addy Alt‐Holland

17 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Addy Alt‐Holland United States 11 226 136 115 81 55 17 476
Takehiko Yamazaki Japan 12 307 1.4× 156 1.1× 80 0.7× 100 1.2× 52 0.9× 20 813
Hanneke N. Monsuur Netherlands 12 273 1.2× 115 0.8× 115 1.0× 47 0.6× 63 1.1× 17 635
Yura Song Belgium 10 218 1.0× 133 1.0× 157 1.4× 66 0.8× 47 0.9× 14 537
Geneviève Chevalier France 9 253 1.1× 211 1.6× 47 0.4× 46 0.6× 47 0.9× 11 549
Kalle Sipilä Finland 11 212 0.9× 85 0.6× 68 0.6× 31 0.4× 56 1.0× 15 470
Priya Govindaraju United States 6 202 0.9× 148 1.1× 243 2.1× 49 0.6× 63 1.1× 7 564
Elke Wandel Germany 7 169 0.7× 61 0.4× 54 0.5× 47 0.6× 85 1.5× 8 375
Holger Schlüter Germany 12 241 1.1× 113 0.8× 68 0.6× 20 0.2× 90 1.6× 21 565
Hans-Jürgen Stark Germany 14 192 0.8× 199 1.5× 111 1.0× 121 1.5× 181 3.3× 17 743
Isabel Arnold Germany 12 720 3.2× 212 1.6× 118 1.0× 94 1.2× 33 0.6× 13 1.0k

Countries citing papers authored by Addy Alt‐Holland

Since Specialization
Citations

This map shows the geographic impact of Addy Alt‐Holland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Addy Alt‐Holland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Addy Alt‐Holland more than expected).

Fields of papers citing papers by Addy Alt‐Holland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Addy Alt‐Holland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Addy Alt‐Holland. The network helps show where Addy Alt‐Holland may publish in the future.

Co-authorship network of co-authors of Addy Alt‐Holland

This figure shows the co-authorship network connecting the top 25 collaborators of Addy Alt‐Holland. A scholar is included among the top collaborators of Addy Alt‐Holland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Addy Alt‐Holland. Addy Alt‐Holland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Alt‐Holland, Addy, Mabi Singh, Athena Papas, et al.. (2023). Identification of Salivary Metabolic Signatures Associated with Primary Sjögren’s Disease. Molecules. 28(15). 5891–5891. 4 indexed citations
2.
Cowan, Janet M., et al.. (2020). Delineating cell behavior and metabolism of non-melanoma skin cancer in vitro. In Vitro Cellular & Developmental Biology - Animal. 56(2). 165–180. 5 indexed citations
3.
Shamis, Yulia, Kyle J. Hewitt, S E Bear, et al.. (2012). iPSC-derived fibroblasts demonstrate augmented production and assembly of extracellular matrix proteins. In Vitro Cellular & Developmental Biology - Animal. 48(2). 112–122. 33 indexed citations
4.
Hewitt, Kyle J., Yulia Shamis, Avi Smith, et al.. (2012). PDGFRβ Expression and Function in Fibroblasts Derived from Pluripotent Cells is Linked to DNA Demethylation. Journal of Cell Science. 125(Pt 9). 2276–87. 30 indexed citations
5.
DesRochers, Teresa M., Yulia Shamis, Addy Alt‐Holland, et al.. (2012). The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma. Epigenetics. 7(1). 34–46. 29 indexed citations
6.
Alt‐Holland, Addy, Claire L. Kublin, David L. Baker, et al.. (2012). Do bib clips pose a cross-contamination risk at the dental clinic?. PubMed. 33(9 Suppl). S1–8. 1 indexed citations
7.
Alt‐Holland, Addy, Adam G. Sowalsky, Yulia Shamis, et al.. (2011). Suppression of E-Cadherin Function Drives the Early Stages of Ras-Induced Squamous Cell Carcinoma through Upregulation of FAK and Src. Journal of Investigative Dermatology. 131(11). 2306–2315. 15 indexed citations
8.
Sowalsky, Adam G., Addy Alt‐Holland, Yulia Shamis, Jonathan A. Garlick, & Larry A. Feig. (2010). RalA Function in Dermal Fibroblasts Is Required for the Progression of Squamous Cell Carcinoma of the Skin. Cancer Research. 71(3). 758–767. 9 indexed citations
9.
Xylas, Joanna, Addy Alt‐Holland, Jonathan A. Garlick, Martin Hunter, & Irene Georgakoudi. (2010). Intrinsic optical biomarkers associated with the invasive potential of tumor cells in engineered tissue models. Biomedical Optics Express. 1(5). 1387–1387. 8 indexed citations
10.
Sowalsky, Adam G., Addy Alt‐Holland, Yulia Shamis, Jonathan A. Garlick, & Larry A. Feig. (2009). RalA suppresses early stages of Ras-induced squamous cell carcinoma progression. Oncogene. 29(1). 45–55. 19 indexed citations
11.
Alt‐Holland, Addy, Yulia Shamis, Kathleen N. Riley, et al.. (2008). E-Cadherin Suppression Directs Cytoskeletal Rearrangement and Intraepithelial Tumor Cell Migration in 3D Human Skin Equivalents. Journal of Investigative Dermatology. 128(10). 2498–2507. 30 indexed citations
12.
Carlson, Mark W., Addy Alt‐Holland, Christophe Egles, & Jonathan A. Garlick. (2008). Three‐Dimensional Tissue Models of Normal and Diseased Skin. Current Protocols in Cell Biology. 41(1). Unit 19.9–Unit 19.9. 109 indexed citations
13.
Zhang, Weitian, Addy Alt‐Holland, Alexander R. Margulis, et al.. (2006). E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion. Journal of Cell Science. 119(2). 283–291. 49 indexed citations
14.
Zhang, Weitian, et al.. (2005). Escape from microenvironmental control and progression of intraepithelial neoplasia. International Journal of Cancer. 116(6). 885–893. 5 indexed citations
15.
Margulis, Alexander R., Weitian Zhang, Addy Alt‐Holland, et al.. (2005). Loss of intercellular adhesion activates a transition from low‐ to high‐grade human squamous cell carcinoma. International Journal of Cancer. 118(4). 821–831. 27 indexed citations
16.
Margulis, Alexander R., Weitian Zhang, Addy Alt‐Holland, et al.. (2005). E-cadherin Suppression Accelerates Squamous Cell Carcinoma Progression in Three-Dimensional, Human Tissue Constructs. Cancer Research. 65(5). 1783–1791. 77 indexed citations
17.
Alt‐Holland, Addy, Wengeng Zhang, A Margulis, & Jonathan A. Garlick. (2004). Microenvironmental control of premalignant disease: the role of intercellular adhesion in the progression of squamous cell carcinoma. Seminars in Cancer Biology. 15(2). 84–96. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026